Skip to main content
The Promise of Adjunct Medications in Improving Type 1 Diabetes Outcomes: Glucagon-Like Peptide Receptor Agonists.
Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes - Case Presentations.
Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System.
The Benefits of Using Continuous Glucose Monitoring to Diagnose Type 1 Diabetes.
Discordance Between Clinician and Person-With-Diabetes Perceptions Regarding Technology Barriers and Benefits.
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.
Time to Moderate and Severe Hyperglycemia and Ketonemia Following an Insulin Pump Occlusion.
Diabetes Technology Meeting 2023.
Update on Measuring Ketones.
Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria.